This site is intended for healthcare professionals
News

Phase III LINC-4 study of Isturisa for the treatment of patients with Cushing’s disease.- Recordati

Read time: 1 mins
Last updated:18th Jun 2020
Published:18th Jun 2020
Condition: Cushing's Syndrome
Type: drug
Register free for full access to medthority.com